VEGF is a pro‐angiogenic factor highly expressed in ovarian cancer, promoting neovascularization and immunomodulation by inhibiting T cell migration and promoting an immunomodulatory T cell phenotype.53, 54. This evidence concerns the gene VEGFA and ovarian carcinoma.